Braun M., Adam M., Pavelka K., Šenolt L.:
Determination of pentosidine in urine and joint compartment
tissues of patients with advanced osteoarthritis
|
59 |
Tegzová D., Jansa P.1, Ambrož D.1, Paleček T.1, Dušek L.2:
The incidence of cardiovascular manifestations
detected by echocardiography in systemic lupus erythematosus
|
64 |
Bečvář R., Vencovský J., Němec P.1, Suchý D.2, Procházková L.1, Pavelka K.:
Recommendations
of Czech Rheumatological Society for the treatment of rheumatoid arthritis. Efficacy and treatment strategies
|
73 |
Štěpán J.:
Monitoring treatment of osteoporosis
|
91 |
Pudlač A.:
Imaging methods for evaluation of the structural changes in ankylosing spondylitis
|
100 |
Šléglová O., Mareček Z.1, Urbánek P.1, Pavelka K.:
Safety of anti-TNF alpha treatment in rheumatic
patients with chronic hepatitis B or C
|
105 |
Skácelová S., Jarošová K., Vencovský J., Gatterová J., Vondřichová H.1, Štěňhová H.1:
Osteonecrosis associated with systemic use of glucocorticoids
|
112 |
Fojtík Z., Kořístek Z., Červinek L., Navrátil M., Obrovská M.:
Thrombotic thrombocytopenic
purpura in patients with systemic lupus erythematosus
|
121 |
